Candriam Equities L Biotech.C EUR/ LU1120766388 /
NAV20.06.2024 | Diff.+2,3300 | Ertragstyp | Ausrichtung | Fondsgesellschaft |
---|---|---|---|---|
223,2300EUR | +1,05% | thesaurierend | Aktien weltweit | Candriam ▶ |
GlobeNewswire
11:00
Defiance Launches QQQT, the NASDAQ 100 Income Target ETF. Seeks 20% annual yield